- Solutions
Our solutions
- OverviewOur workflow solutions give you the data, tools, and insights to power every decision
- Strategic IntelligenceGet a complete view of strategic issues and stay ahead of emerging disruptive themes
- Sales IntelligenceOur workflow solutions give you the data, tools, and insights to power every decision
- Industry
- Platform
Our platform
Your powerful intelligence platform
Explore the fully comprehensive productivity and insights platform
- Company
We are GlobalData
Amidst the COVID-19 pandemic, India’s sterilization market witnessed a remarkable transformation, where sterilization devices emerged as unwavering defenders of healthcare, safeguarding countless lives. As the demand for sterilization methods continue to increase owing to the growing awareness of disinfection and sterilization among healthcare personnel and general population, the sterilization equipment market in India is expected […]
Abbott Laboratories’ US withdrawal of Trifecta valves will benefit Edwards Lifesciences, says GlobalData
Abbott Laboratories’ Trifecta GT aortic valve has been in use to treat damaged native or prosthetic aortic heart valves since its FDA approval in 2016. However, the company recently announced that they will be withdrawing the product line from the US tissue sutured aortic valve replacement (sAVR) market. The withdrawal is expected to benefit Edwards […]
China chemiluminescence analyzers market to reach $45 million by 2033, forecasts GlobalData
Owing to the growing number of cases with infectious and cardiovascular diseases, chemiluminescence analyzers are gaining interest in China due to their high sensitivity and specificity. Against this backdrop, China’s chemiluminescence analyzers market is anticipated to reach $45 million in 2033, forecasts GlobalData, a leading data and analytics company. GlobalData’s report, ‘Immunochemistry Analyzers Market Size […]
Australia cardiovascular devices market to grow at 8% CAGR through 2030, forecasts GlobalData
The Australian government recently updated its cardiovascular disease guidelines aimed at improving time to diagnosis and treatment, as part of its focus on preventative measures for cardiac health. Against this backdrop, Australia’s cardiovascular devices market is set to grow at a compound annual growth rate (CAGR) of over 8% between 2023 and 2030, forecasts GlobalData, […]
Australia telehealth devices market to grow at 10% CAGR through 2030, forecasts GlobalData
Australia is making impressive strides in telehealth advancements, capitalizing on the integration of technology in healthcare. Against this backdrop, Australia’s telehealth devices market is set to grow at a compound annual growth rate (CAGR) of around 10% between 2023 and 2030, forecasts GlobalData, a leading data, and analytics company. GlobalData’s report, ‘Telehealth Market Size (Value, Volume, […]
Digitally enabled devices to drive continuous glucose monitors and insulin pumps market to $20.8 billion in 2033, forecasts GlobalData
Amidst the COVID-19 pandemic, digitally enabled devices like continuous glucose monitors (CGMs) witnessed significant growth, highlighting their popularity. These devices greatly aid healthcare providers and patients in enhancing glycemic control and potentially boosting patient self-management. Against this backdrop, the CGM and insulin pumps market is projected to nearly double from $10.6 billion in 2022 to […]
Product recalls threaten Medtronic’s position in implantable cardioverter defibrillator market, says GlobalData
Medtronic recently issued a recall for its nearly 350,000 implantable cardioverter defibrillator (ICD) devices, which include product lines such as Cobalt, Evera and Visia. These products are their most prominent devices and, in the past, have established Medtronic as the market leader, accounting for an estimated 40% of the ICD market. Against this backdrop, the […]
Alarming surge in healthcare cybersecurity breaches warrants improved protection measures, says GlobalData
The healthcare industry’s rapid adoption of digital health services and the progression of interconnected devices have revolutionized patient care and operational efficiency. However, this digital transformation has also exposed healthcare systems to a mounting wave of cyberattacks, which warrant improved protection measures, says GlobalData, a leading data and analytics company. According to GlobalData’s Q2 2023 […]
QuidelOrtho’s triage test recall massive blow to multi-parameter cardiac marker tests market in US, says GlobalData
On July18, 2023, the FDA released a Class I tag on the Quidel Triage Cardiac Panel, which means usage of the product may lead to serious injury or death without action. There were numerous complaints received that demonstrated that the test’s ability to detect troponin was faulty as it showed lower-than-expected troponin levels. This could […]
Alzheimer’s disease market poised for 29% CAGR through 2030 with precision medicine and neuromodulation innovations, forecasts GlobalData
The global Alzheimer’s disease (AD) market is expected to grow at a compound annual growth rate (CAGR) of 29% to reach $16 billion in 2030. Major driving factors of this growth include an ageing global population leading to an increase in prevalent cases, the launch of novel symptomatic therapies and innovations in precision medicine and […]
China laparoscopic trocars market poised to reach $30 million by 2030, forecasts GlobalData
Being home to the largest elderly population in the world, China has a high prevalence of metabolic and chronic diseases. Elderly patients remain physically and emotionally vulnerable to surgical treatments and operations to treat such medical conditions. Laparoscopy is one of the most preferred minimally invasive techniques that improve surgical outcomes in the elderly population. […]
Quest Diagnostics launch of DTC genetic test momentous event, says GlobalData
Quest Diagnostics has launched a direct-to-consumer (DTC) genetic test “Genetic Insights”, highlighting the continued growth potential of the market. This is in large part due to more consumers becoming eager to learn their genetic profiles and make decisions about their health, or to simply gain knowledge of their ancestral information, says GlobalData, a leading data […]
Advancements in wearable technology revolutionizing fitness and wellness landscape, says GlobalData
The month of July is a time dedicated to celebrating fitness and wellness, providing an excellent opportunity to explore the latest advancements in wearable technology. With the growing emphasis on leading a healthy lifestyle, wearable technology has become increasingly sophisticated, offering a range of features to track and analyse fitness-related data. With the integration of […]
GenAI making waves in medical device industry, says GlobalData
Generative artificial intelligence (GenAI) is impacting every industry and the medical device industry is no exception. From crunching massive data sets for R&D breakthroughs to mimicking human speech for improved patient care, the technology is making waves. GenAI is being implemented across the medical value chain for applications ranging from research & development, imaging & […]
Hepatitis B burden places China at an elevated risk of liver cancer, forecasts GlobalData
Hepatitis B has long been known to be one of the biggest risk factors for primary liver cancer. Liver cancer and cirrhosis brought on by chronic hepatitis account for the vast majority of fatalities in China, that has been associated with a high incidence of HBV infection worldwide. Against this backdrop, China’s hepatitis B tests […]
Wearable tech market poised to reach $156 billion in 2024, forecasts GlobalData
The market for wearables has been growing significantly in the medical device industry over the past several years. Wearables have the potential to address spiralling healthcare costs, aging populations, and the burden of chronic disease. Against this backdrop, the market for wearable technology is set to grow at a compound annual growth rate (CAGR) of […]
AI in oncology IVD products will drive cancer diagnosis advancements, says GlobalData
Currently, there are 569 clinical trials focused on developing in vitro diagnostic (IVD) devices in oncology out of 1,490 active clinical trials. Out of the total IVD trials, nine are being conducted to test partial or full analysis by artificial intelligence (AI) to improve oncology diagnosis. AI-driven machine learning is pushing the advancement of IVD […]
Australia colorectal cancer screening market to reach $10 million by 2030, forecasts GlobalData
The Australian Government has recently partnered with the Cancer Council of Australia to launch a nationwide colorectal cancer screening campaign, in response to the increasing prevalence of colorectal cancer and declining screening rates. Against this backdrop, the Australian colorectal cancer screening tests market is forecast to reach $10 million in 2030, according to GlobalData, a […]
Major companies still innovating in mature pacemaker space, finds GlobalData
Pacemaker technology has come a long way since its first implantation in the 1950s. Over the years, there have been significant developments in pacemaker technology—such as making smaller devices, more efficient pacing technology, and wireless communication. While pacemakers are considered a relatively mature market, this has not prevented major companies from innovating new products, says […]
South Korea oncology tests market set for 2% CAGR through 2030, forecasts GlobalData
Lung cancer is one of the leading causes of cancer-related deaths in South Korea and globally. Most lung cancer patients are diagnosed at an advanced stage and often respond poorly to treatment. Therefore, there is a growing demand for new screening technologies for the early detection of lung cancer. Against this backdrop, South Korea’s oncology […]